Clive Palmer and his company Mineralogy have lost a challenge to a Western Australia Supreme Court decision staying a $263 million lawsuit against Hong Kong-based CITIC, with an appeals court finding the mining giant’s decision to abandon and relitigate matters amounted to “unjustified trouble and harassment”.
Law firms are ordering staff in their Sydney offices to work from home if possible and avoid face-to-face meetings as the state’s new rules requiring masks at all indoor workplaces takes effect.
Oracle has settled a lawsuit brought by a former account director who claimed he was fired for making complaints about one of his superiors who allegedly told him he had “zero EQ” and “an innate ability to annoy and anger people”.
The ATO is challenging a judge’s decision to allow oil giant Shell Australia $2.2 billion in deductions for the cost of certain exploration activities conducted under an acquisition that increased its stake in Woodside Energy’s Browse Basin gas exploration joint venture project.
The lead applicants in a class action against two CBA units over allegedly excessive insurance premiums have been ordered to amend their pleadings to expand the group definition and add more detail to their claims.
Industry super funds AustralianSuper and IFM Investors – the consortium behind the interest rate swap at the centre of the corporate watchdog’s insider trading case against Westpac — have asked a judge to shield commercially sensitive information from the public as the high-profile action unfolds.
A judge has awarded $43 million to National Australia Bank in its lawsuit against former directors of failed retailer Dick Smith, but threw out claims against company directors brought by HSBC and the retailer’s receivers.
Westpac has shot back at a lawsuit brought by ASIC over the selling of alleged poor value insurance products, with the bank saying its customers had agreed to take out the “optional” coverage.
A Federal Court judge has made his feelings known about a ruling by the NSW Supreme Court last year that found judges have no power to shut unregistered group members out of a class action, but said he was “just a single judge” and was bound by the decision.
A judge has given Generic Health more time to file its evidence in a multimillion-dollar dispute with drug makers Otsuka and Bristol-Myers Squibbs over the delayed launch of generic versions of their antipsychotic drug Abilify, but warned there had to be a cut-off point for preparing the decade-long dispute for trial.